MNTL TEMA NEUROSCIENCE AND MENTAL HEALTH ETF
- 25.420
- +0.229+0.91%
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Catalyst Watch: Robotaxi IPO, OPEC+, Holiday Shopping Data, and Movie Blockbusters
Sanofi Becomes Latest Drugmaker to Challenge HHS Over 340B Drug-discount Program
Market Climbs, Bitcoin Close to $100k | Live Stock
Novo Nordisk Said to Have Contracted Ypsomed to Make Next Gen Obesity Drug's Pens
Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Hims & Hers Closes up 10% as Lilly Tirzepatide Compounding Dispute Resolution Delayed
Optimism Over Global Healthcare Sector Rises: Jefferies
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Mizuho Maintains Outperform on Biogen, Lowers Price Target to $207
Biogen Analyst Ratings
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
Eli Lilly in Pact With Chinese Biotech for Novel Weight Loss Therapy
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
Goldman's Hedge Fund VIP List: AMZN, VST, CRM, BABA, and More